Genentech profit up 41 percent on Rituxan, Avastin
688355
Genentech Inc.  said on Wednesday that second-quarter profit rose 41 percent, fueled by growth from cancer drugs Rituxan and Avastin.
43644
Schering-Plough Corp.  said on Monday that second-quarter earnings rose sharply, fueled by growing demand for its Zetia and Vytorin cholesterol drugs and treatments for arthritis and allergies.
736084
Biogen Idec Inc.  said on  Thursday that fourth-quarter earnings rose on higher sales of  its cancer and multiple sclerosis drugs.
636969
Abbott Laboratories Inc. ABT.N on  Tuesday said its fourth-quarter profit rose 3.2 percent on  higher sales of its prescription drugs, including its popular  new treatment for rheumatoid arthritis, Humira.
272056
The Swiss pharmaceuticals giant Roche, manufacturer of anti-flu drug Tamiflu, said its first-half net profit had increased by 37 percent to 4.54 billion Swiss francs (2.9 billion euros, 3.62 billion dollars).
464346
The drugmaker posted third-quarter net income of $1.53 billion as revenues increased by double digits, while lower  costs offset more spending on research and development.
681279
Genentech Inc said on Tuesday its cancer drug, Avastin, met the primary goal of prolonging progression-free survival when combined with chemotherapy in a breast cancer study, sending its shares up more than 3 percent.
15948
Genentech reported a 6 percent rise in fourth-quarter profit, but its stock slipped after news that its cancer drug, Avastin, failed to meet sales expectations.
447460
Biotechnology company Genzyme Corp   reported a fourth-quarter profit on Wednesday,  reversing a year-earlier loss, as sales of its drugs for rare  diseases increased.
229274
Genentech, the biotechnology company, posted a 41 percent increase in second-quarter profit on sales of its cancer drugs, continuing a positive earnings streak.
365281
Genentech Inc.  said on  Tuesday second-quarter profit rose 79 percent on demand for  cancer medicines and raised its full-year forecast, but its  stock fell as sales of colon cancer drug Avastin disappointed.
271064
Profits at the drugmaker increased 13 percent in the second quarter on higher sales of its arthritis drug and pneumonia vaccine.
765525
Gilead Sciences Inc. GILD.O on  Thursday said its quarterly net profit rose 55 percent on  increased sales of its HIV drugs.
704563
Genentech's cancer drug Avastin helped patients with advanced kidney cancer live twice as long as those on standard therapy alone, according to a study released on Saturday.
719738
Genentech Inc. on Monday said its colon cancer drug Avastin extended the life of patients when used in combination with a chemotherapy regimen called FOLFOX4 more than the chemotherapy alone in a late stage clinical trial.
455151
Australian pathology and radiology group Sonic Healthcare Ltd has reported a 41 percent jump in annual net profit, boosted by its UK expansion and higher government payouts for blood tests.
360406
Abbott Laboratories Inc. ABT.N on  Tuesday said its fourth-quarter profit rose 3.2 percent, helped  by surging sales of two arthritis drugs, including one that  many doctors now deem safer than newer treatments such as  Pfizer Inc.'s Celebrex.